Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.40 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7469284 | 0.95 | ALOX15 (0.47) | CYP19A1NPC1RAB9ACYP2A6TLR8 | |
| SCHEMBL7463986 | 0.94 | MAPT (0.48) | CYP19A1NPC1RAB9ACYP2A6TLR8 | |
| SCHEMBL6301307 | 0.90 | CYP19A1 (0.49) | CYP19A1NPC1RAB9ACYP2A6TLR8 | |
| SCHEMBL2785591 | 0.83 | CYP19A1 (0.47) | CYP19A1NPC1RAB9ACYP2A6USP2 | |
| SCHEMBL30317998 | 0.82 | CYP19A1 (0.51) | CYP19A1NPC1RAB9ACYP2A6USP2 | |
| SCHEMBL6300586 | 0.82 | CYP19A1 (0.51) | CYP19A1NPC1RAB9ACYP2A6USP2 | |
| SCHEMBL12370192 | 0.81 | TLR8 (0.44) | TLR8MAOAALOX15F2F10 | |
| SCHEMBL2330441 | 0.80 | ALOX15 (0.58) | TLR8MAOAALOX15F2F10 | |
| SCHEMBL8950010 | 0.80 | ALDH1A1 (0.50) | CYP19A1NPC1RAB9ACYP2A6USP2 | |
| SCHEMBL284155 | 0.80 | TLR8 (0.50) | NPC1TLR8MAOAALOX15F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115521277-A | Method for preparing benzofuran compound | 山东新时代药业有限公司 | 2022-12-27 | — | — | CN | disclosed |
| EP-3039016-B1 | PROCESS FOR PREPARING DRONEDARONE AND SALTS THEREOF | GILEAD SCIENCES INC (US) | 2017-08-02 | — | — | EP | disclosed |
| US-9334254-B2 | Process for preparing sulfonamidobenzofuran derivatives | SANOFI (FR) | 2016-05-10 | — | — | US | disclosed |
| US-9242953-B2 | Process for preparing dronedarone and salts thereof | GILEAD SCIENCES, INC. (US) | 2016-01-26 | — | — | US | disclosed |
| US-9242953-B2 | Process for preparing dronedarone and salts thereof | GILEAD SCIENCES, INC. (US) | 2016-01-26 | — | — | US | disclosed |
| WO-2015031352-A1 | PROCESS FOR PREPARING DRONEDARONE AND SALTS THEREOF | GILEAD SCIENCES, INC. (US) | 2015-03-05 | — | — | WO | disclosed |
| US-20150065734-A1 | PROCESS FOR PREPARING DRONEDARONE AND SALTS THEREOF | GILEAD SCIENCES, INC. (US) | 2015-03-05 | — | — | US | disclosed |
| US-20150065734-A1 | PROCESS FOR PREPARING DRONEDARONE AND SALTS THEREOF | GILEAD SCIENCES, INC. (US) | 2015-03-05 | — | — | US | disclosed |
| US-8871956-B2 | Method for preparing 3-keto-benzofurane derivatives | SANOFI (FR) | 2014-10-28 | — | — | US | disclosed |
| US-20130165673-A1 | METHOD FOR PREPARING 3-KETO-BENZOFURANE DERIVATIVES | SANOFI (FR) | 2013-06-27 | — | — | US | disclosed |
| US-20130046103-A1 | PREPARATION OF BENZOFURANS AND USE THEREOF AS SYNTHETIC INTERMEDIATES | MAPI PHARMA LIMITED (IL) | 2013-02-21 | — | — | US | disclosed |
| US-20130046103-A1 | PREPARATION OF BENZOFURANS AND USE THEREOF AS SYNTHETIC INTERMEDIATES | MAPI PHARMA LIMITED (IL) | 2013-02-21 | — | — | US | disclosed |
| EP-2552899-A1 | PROCESS FOR PREPARING SULFONAMIDO-BENZOFURAN DERIVATIVES | SANOFI (FR) | 2013-02-06 | — | — | EP | disclosed |
| EP-2552898-A1 | METHOD FOR PREPARING 3-KETO-BENZOFURANE DERIVATIVES | SANOFI (FR) | 2013-02-06 | — | — | EP | disclosed |
| US-20130023678-A1 | PROCESS FOR PREPARING SULFONAMIDOBENZOFURAN DERIVATIVES | SANOFI (FR) | 2013-01-24 | — | — | US | disclosed |
| EP-2533636-A1 | PREPARATION OF BENZOFURANS AND USE THEREOF AS SYNTHETIC INTERMEDIATES | Mapi Pharma Limited (IL) | 2012-12-19 | — | — | EP | disclosed |
| CN-102753018-A | Preparation of benzofurans and their use as synthetic intermediates | MAPI PHARMA HOLDINGS CYPRUS LTD | 2012-10-24 | — | — | CN | disclosed |
| WO-2011131881-A1 | METHOD FOR PREPARING 3-KETO-BENZOFURANE DERIVATIVES | SANOFI-AVENTIS (FR) | 2011-10-27 | — | — | WO | disclosed |
| WO-2011124827-A1 | PROCESS FOR PREPARING SULFONAMIDO-BENZOFURAN DERIVATIVES | SANOFI-AVENTIS (FR) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011099010-A1 | PREPARATION OF BENZOFURANS AND USE THEREOF AS SYNTHETIC INTERMEDIATES | MAPI PHARMA HOLDINGS (CYPRUS) LIMITED (CY) | 2011-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165673-A1 | METHOD FOR PREPARING 3-KETO-BENZOFURANE DERIVATIVES | CYP2F1, CBR3, STS | CYP19A1 520/4885NPC1 3779/4885RAB9A 2035/4885 |
| US-20150065734-A1 | PROCESS FOR PREPARING DRONEDARONE AND SALTS THEREOF | CYP2D6, CYP3A43, CYP3A4 | CYP19A1 631/4885NPC1 303/4885RAB9A 144/4885 |
| US-20130046103-A1 | PREPARATION OF BENZOFURANS AND USE THEREOF AS SYNTHETIC INTERMEDIATES | CYP2F1, CYP4F3, CYP2D6 | CYP19A1 319/4885NPC1 1648/4885RAB9A 1482/4885 |
| US-20130023678-A1 | PROCESS FOR PREPARING SULFONAMIDOBENZOFURAN DERIVATIVES | CYP2F1, STS, SULT1E1 | CYP19A1 878/4885NPC1 4109/4885RAB9A 2601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.